ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

CLLS Cellectis SA

2.57
-0.10 (-3.75%)
2024年6月8日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Cellectis SA CLLS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.10 -3.75% 2.57 07:04:11
始値 安値 高値 終値 前日終値
2.64 2.5602 2.64 2.57 2.67
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0505:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/0505:30GLOBECellectis Receives Orphan Drug Designation for UCART22, its..
2024/5/3005:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/3005:30GLOBECellectis’ Annual Shareholders General Meeting to be Held on..
2024/5/2905:30GLOBECellectis Reports Financial Results for First Quarter 2024
2024/5/2819:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2805:30GLOBECellectis to Report First Quarter 2024 Financial Results on..
2024/5/2505:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/0619:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/0615:00GLOBECellectis Announces Completion of the Additional Equity..
2024/5/0305:30GLOBECellectis Appoints Arthur Stril as Interim Chief Financial..
2024/4/3005:46GLOBECellectis Reports Financial Results for the Fourth Quarter..
2024/4/2305:30GLOBECellectis Presents Novel TALEN® Editing Processes Enabling..
2024/4/1105:30GLOBECellectis Publishes a Novel Intronic Gene Editing Approach..
2024/4/0905:30GLOBECellectis Announces Two Poster Presentations on Novel TALEN®..
2024/1/1706:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/1706:30GLOBECellectis announces the drawdown of the second tranche of..
2023/12/2306:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2306:30GLOBECellectis Reports Results from Shareholders Meeting Held on..
2023/12/2306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0606:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1806:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1806:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1806:30GLOBECellectis’ Shareholders Meeting to be Held on December 22,..
2023/11/1521:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1516:30GLOBECellectis Announces the execution of the Subsequent..
2023/11/1006:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0706:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0706:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0706:30GLOBECellectis Reports Financial Results for Third Quarter and..
2023/11/0305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0305:30GLOBECellectis to Present Preliminary Results of NATHALI_01 and..
2023/11/0205:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0205:30GLOBECellectis to Report Third Quarter 2023 Financial Results on..
2023/11/0204:15APSBiotech Shares Soar After AstraZeneca Stake & Research..
2023/11/0120:52DJNCellectis Shares Soar Premarket on AstraZeneca Deal
2023/11/0120:51DJNCellectis Shares Soar Premarket on AstraZeneca Deal
2023/11/0119:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0117:17DJNAstraZeneca to Invest $245 Million in Deal With Cellectis
2023/11/0116:00GLOBECellectis Announces Strategic Collaboration and Investment..
2023/11/0106:10EDGAR2Form 20-F/A - Annual and transition report of foreign..
2023/11/0106:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0105:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0105:30GLOBECellectis Presents Pre-Clinical Data on Multi-armored..
2023/10/2505:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1305:30GLOBECellectis and Imagine Institute Publish A Proof-Of-Concept..
2023/9/2805:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2805:30GLOBECellectis to Present Pre-Clinical Data on Multi-armored..
2023/9/0605:32EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..

最近閲覧した銘柄

Delayed Upgrade Clock